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esponsibility of Xi’Abstract A furano-diterpene (polyalthic acid) was isolated as a major stable compound for the ﬁrst time
from the oleoresin of the Daniella oliveri of the family Caesalpiniacea through column chromatography
fractionation. Polyalthic acid was characterized using data obtained from EIMS, HREIMS, ESI-MS,
MALDI-MS as well as 1D and 2D NMR and it was evaluated for its potential to inhibit the formation of
advanced glycation end-products (AGEs) using a standard in vitro antiglycation procedure. Polyalthic acid
indicated a negative antiglycation potential compared to standard inhibitor that has 85% inhibition, which
is an indication that polyalthic acid may not contribute to the antiglycation activity of the plant as
acclaimed in folkloric medicine. The negative antiglycation observed could indicate that the polyalthic
acid could trigger glycation, thereby subjecting users to various degrees of complications. The bioactivity
evaluation on molinspiration evaluator indicated that polyalthic acid could be a potential drug candidate.
The biological and chemical insights gained on polyalthic acid provide a good basis for future research.
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Oxygenated heterocyclic diterpenes are of great medicinal value
well known to possess various degrees of important pharmacolo-
gical activities. Carnosic acid and carnosol (oxygenated diter-
penes) from ethanolic extracts of dried leaves of sage (Salvia
ofﬁcinalis) have shown inhibition of (35S)tert-butylbicyclopho-
sphorothionate(35S-TBPS) binding to rat brain membranes in an
in vitro model [1]. The compounds were later observed to be
strong antioxidants [2], activators of the human peroxisomeier B.V. All rights reserved.
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anti-angiogenic activity which possibly contributes to the chemo-
preventive, antitumoral and antimetastatic activities of rosemary
extracts [4]. Recently, eight new cassane-type heterocyclic diter-
penes were isolated from the ethyl acetate extract of Caesalpinia
minax and they were observed to possess signiﬁcant antiprolifera-
tive activity against various cell lines [5]. Our interest was drawn
to polyalthic acid, a bicyclic diterpene which is present in the
exudates of Daniella oliveri as indicated in our preliminary
ﬁndings. Literature search revealed that heterocyclic diterpenes
have been isolated from this plant previously. Speciﬁcally,
compounds isolated from D. oliveri wood include a diterpene
lactone [6], daniellic acid and daniellic alcohol [7]. The biological
signiﬁcance of these diterpenes has not been established.
D. oliveri, a deciduous wood plant belonging to the family
Caesalpiniacea, is known for the production of aromatic resins
which are used as a mosquito repellent in various African
countries [8]. The bark and wood are also burnt to act as mosquito
repellants in some countries [9,10]. The bark extract is used
traditionally for control of gastro-intestinal parasites [11], while
the decoction of the root extract with other plant extracts is used in
some parts of Southern Nigeria as remedy for hyperglycemia [12].
The leaf extract has been reported for its in vitro antioxidant
potential [13], antimicrobial activities [14,15], in vivo anti-typhoid
potential [16] and effect on skeletal muscles of experimental
animals [17]. The resinous exudate obtained from the bark of the
plant is used for wound healing purposes in Nigeria [18]. The
exudate also possesses anti-wrinkle potential [19]. The gum and
bark are taken in various preparations, internally and externally,
and sometimes with other plant parts, to treat venereal diseases,
ulcers and sores, circumcision wounds, leprosy, dysentery, colic,
menstrual problems, cough, colds, angina, bronchitis, tuberculosis,
kidney problems, appendicitis, headache, back-ache, rheumatism,
fever pains, hernia, tooth-ache and snakebites [20]. In this paper
we report for the ﬁrst time the isolation, characterization and
antiglycation activity of polyalthic acid from D. oliveri exudate.2. Materials and methods
Plant materials were collected from mature D. oliveri tree at Ilorin,
Nigeria. Botanical authentication was performed by a plant
taxonomist at the Herbarium of the Department of Plant Biology,
University of Ilorin, Ilorin, Nigeria and a voucher specimen
number UIH 964 was obtained. The resin was stored in a cool
place until further use.2.1. Isolation of polyalthic acid
Approximately 2 g of the plant exudates were dissolved in
dichloromethane (DCM) and fractionated on a silica gel column
chromatography eluting with hexane: DCM in an increasing order
of polarity. Fractions were obtained and proﬁled on thin layer
chromatography (TLC). Most fractions were too complex to be
separable as they contained numerous compounds in minute
quantities and were therefore not further processed. The fraction
containing a major compound (semi pure) was re-chromato-
graphed on a silica gel column chromatography using hexane:
DCM in an increasing order of polarity to furnish a compound,
which was later identiﬁed as polyalthic acid.2.2. Instruments
Electron-impact mass spectra (EI-MS) were obtained on a variant
MAT 311 mass spectrometer connected to a computer system.
High-resolution electron impact mass (HREI-MS) spectra were
recorded on a JEOL-JMS HX 110 mass spectrometer. ESI-MS
data were obtained on QqTOF-MS/MS instrument (QSTAR XL
mass spectrometer Applied Biosystem/MDS Sciex, Darmstadt,
Germany) at room temperature. Samples were dissolved in
appropriate polar solvent, and working dilution was prepared in
acetonitrile-water containing 0.1% triﬂuoroacetic acid. Analysis
was carried out by electrospray ionization (ESI) and collision-
induced dissociation (CID), positive ion mode on the instrument at
room temperature. Matrix assisted laser desorption/ionization
(MALDI) mass spectrum data were obtained on a Ultraﬂex TOF
(Bruker Daltonics, Bremen, Germany) mass spectrometer,
equipped with a Smart beam laser (Nd: YAG, 355 nm) and an
electrostatic reﬂector. Infrared spectra were determined on a
JASCO A-302 spectrophotometer Fourier Transform-Infrared
(FTIR) spectrophotometer using KBr pellet. Nuclear magnetic
resonance (NMR) spectra were recorded on a Bruker AM-400
spectrometer. Multiplicity of the carbon signals was determined by
using DEPT 901 and 1351 experiments. Homonuclear 1H–1H
connectivities were determined by using COSY 451 experiment.
One bond 1H–13C bond connectivities were determined by using
HMQC experiment. Two- and three-bond 1H–13C connectivities
were determined by HMBC experiment. Tetramethylsilane (TMS)
was used as the internal reference. All NMR spectra were
measured in CDCl3.
2.3. In vitro antiglycation assay
The in vitro antiglycation potential of polyalthic acid isolated from
D. oliveri was evaluated following standard procedure [21], by
dissolving 10 mg/mL bovine serum albumin (BSA) in 67 mM
phosphate buffer (pH 7.4). Glucose (50 mg/mL) was dissolved in
67 mM phosphate buffer (pH 7.4). 3 mM sodium azide was added
to inhibit bacterial growth. 1 mg/mL concentration of the extract
was used to calculate antiglycation activity along with the standard
inhibitor. The dissolved samples (60 mL in each well of 96-well
plate) were incubated for a week at 37 1C. After a week, the
samples were allowed to cool to room temperature. Then 6 μL of
100% trichloroacetic acid (TCA) was added to each of the well
and the supernatants containing unbounded glucose, inhibitor and
interfering substances were removed after centrifugation at
14,000 rpm for 4 min. Pellets were obtained at the bottom of the
wells. Solvent was removed from each well and 60 mL of
phosphate buffer saline (PBS) pH 10 was added to dissolve the
pellets and the comparison of ﬂuorescence intensity at 370 nm
excitation and emission at 440 nm was made using a spectro-
ﬂuorimeter, RF-1500 Shimadzu, Japan. Rutin was used as the
standard inhibitor. Inhibition percentage was calculated as
% inhibition¼ 100½ðODsample=ODblankÞ  100;
where ODsample and ODblank are the optical densities of sample and
blank, respectively.
2.4. Data analysis
The 50% cytotoxic (IC50) was calculated from dose-response-
inhibition curves after nonlinear regression analysis. The results
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Fig. 2 Structure of rutin.
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three different experiments.2.5. Spectroscopic data of polyalthic acid
Polyalthic acid, C20H28O3 (19 mg); EI-MS m/e: (M
þ) 316 (34%),
189 (34%), 121 (89%), 81 (100%); UV λmax 248 nm; IR (KBr)
cm1: 3415 (O–H stretch), 2959 and 2871 (C–H stretch), 1712
(CQO stretch of carboxylic acid), 1665 (CQC stretch), 1453
(O–H bend), 1214 (C–O–C ether) and 900 (C–H bend) and 889
(furan ring): HREIMS; 316.2028 amu; calc. 316.20 indicating
C20H28O3. MALDI-TOF; [MþH]þ 317: ESI-TOF-MS; [MþH]þ
317. NMR (CDCl3 ppm): 0.78 (3H, CH3), 1.21(3H, s, CH3)
1.3–2.57 (16H, M, –CH2– and –CH–), 4.56 and 4.87(1H each,
s and –CH), 6.23 (1H, s, proton on furan ring), 7.17 and 7.32 (1H
each s, protons on furan ring), 9.40 (lH, brs, COOH). Other NMR
data which include COSY, HMQC, HMBC and NOESY were
examined and compared with the data in literature [22,23].3. Results and discussion
Polyalthic acid (Fig. 1) has two C-Me groups [23] and the NMR
spectrum of polyalthic acid in CDCl3 distinctly revealed two
tertiary methyl groups at δ 0.78 and 1.21 ppm, one being more
deshielded than the other due to the proximity of a carboxyl group
on ring A, 14 cyclic methine and methylene protons, an exocyclic
methylene group and two α and one β-furan protons. The two
exocyclic vinyl protons were well discernable at δ 4.56 and
4.87 ppm and the furan ring protons at δ 7.17 and 7.32 ppm. Thus,
the compound was identiﬁed as polyalthic acid. The formation of
advanced glycation end-products (AGEs) otherwise known as
antiglycation indicated that the compound has a negative anti-
glycation potential when compared with the standard inhibitor
drug, rutin (Fig. 2) which had 85% inhibition at 1 mM concentra-
tion and an IC50 of 269.0473.79 mg/mL. Consequently, poly-
althic acid may not be a primary component responsible for the
antidiabetic activity reported for the plant extract in folkloric
medicine and in vivo studies [12]. The negative antiglycation
observed could be an indicator that polyalthic acid could triggerglycation, thereby subjecting users to various degrees of
complications.
In previous research, polyalthic acid has been isolated from
Polyalthia fragrans [24] and reported to suppress the mutagenicity
of Trp-P-1 [25]. It has also been shown that kaurenoic and
polyalthic acids are capable of promoting the inhibition of
rhodamine 6G efﬂux in Saccharomyces cerevisiae with Pdr5p
enzyme, the protein that confers multiple drug resistance [26].
Polyalthic acid isolated from Croton reﬂexifolius was identiﬁed
as the main active relaxing agent when assessed in isolated guinea
pig tracheal rings [27] and was reported to be a gastro-protector
agent in animal studies. Polyalthic acid used to treat rats orally
showed a gastro-protective effect similar to that elicited by
carbenoxolone [28].
The online chemoinformatics software Molinspiration (version
2011.06) was used to establish the molecular properties (Table 1)
and drug-likeness/bioactivity score of polyalthic acid compared
with the standard, rutin (Table 2). Drug-likeness is based on
Lipinski’s “Rule of 5” [29], which considers whether various
molecular properties and structure features of a particular molecule
are similar to those of known drugs. These properties, such as
hydrophobicity, electron distribution, hydrogen bonding character-
istics, molecule size and ﬂexibility, inﬂuence the absorption,
bioavailability, transport properties, reactivity, toxicity, metabolic
stability of the molecule and thus potential for use as a
pharmaceutical drug [29,30].
The rule was formulated by Lipinski et al. [29]. The rule
describes molecular properties important for a drug’s pharmaco-
kinetics in the human body, including their absorption, distribu-
tion, metabolism and excretion (ADME). The rule is important for
drug development where a pharmacologically active lead structure
is optimized stepwise for increased activity and selectivity, as well
as drug-like properties [31]. Polyalthic acid and rutin were checked
for the bioactivity by calculating the activity score for GPCR
ligand, ion channel modulator, kinase inhibitor, and nuclear
receptor ligand [29].
Rutin violated three of the Lipinski’s rules while polyalthic acid
violated none (Table 1). The positive bioactivity score of poly-
althic acid, especially its ability to act as nuclear receptor ligand
and enzyme inhibitor, is a clear indication that the compound is a
potential drug candidate. It can be a viable lead compound in the
development of drug through structure activity relationship
studies.
Table 1 Molecular properties of polyalthic acid and rutin.
Compound MW/formula Log Pa Molecular polar surface
area/volume
No. non-H
atoms
No. H bond
acceptorsb
No. H bond
donorsc
Rotatable
bonds
No. of rule of ﬁve
violationsd
Polyalthic
acid
316.441 4.689 50.439/316.057 23 3 1 4 0
C20H28O3
Rutin 610.521 1.063 269.427/496.068 43 16 10 6 3
C27H30O16
MW: molecular weight.
aLog P is based on octanol–water partition coefﬁcient.
bH bond acceptors include O and N atoms.
cH bond donors include OH and NH groups.
dRule of 5 violations are based on the molecular descriptors used by Lipinski et al. [29] for “drug-like” molecules (log pr5, molecular weight
r500, number of hydrogen bond acceptors r10, and number of hydrogen bond donors r5).
Table 2 Bioactivity score of polyalthic acid and rutin.
Compound GPCR
ligand
Ion channel
modulator
Kinase
inhibitor
Nuclear receptor
ligand
Protease
inhibitor
Enzyme
inhibitor
Polyalthic acid 0.38 0.28 0.42 0.80 0.13 0.60
Rutin 0.05 0.52 0.14 0.23 0.07 0.12
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Polyalthic acid, a diterpenoid isolated for the ﬁrst time from
exudates oleoresin of D. oliveri, indicated no antiglycation
potential. Other biological assays would be substantive to amply
validate the pharmacological signiﬁcances of polyalthic acid
obtained in the plant. The biological and chemical insights on
polyalthic acid provide a good basis for future research.Acknowledgments
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